Promentis Pharmaceuticals, Inc. — Form D

Promentis Pharmaceuticals, Inc. of MILWAUKEE, WI, a company, filed a Form D exempt-offering notice with the SEC on 2009-08-28. The offering totals $2.5M, of which $1.7M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (27)

Showing 25 of 27 people.

NameRoleLocation
Klaus VeitingerDirectorChanhassen, MN
Klaus VeitingerExecutive OfficerChanhassen, MN
Stacey SeltzerDirectorSan Diego, CA
Chad BeyerExecutive OfficerMilwaukee, WI
Steve SquintoDirectorMilwaukee, WI
Thomas BeckDirectorMilwaukee, WI
Patrick Schwarz-SchuetteDirectorMilwaukee, WI
Daniel LawtonDirectorMilwaukee, WI
Daniel LawtonExecutive OfficerMilwaukee, WI
Tom BeckDirectorMilwaukee, WI
Tom BeckExecutive OfficerMilwaukee, WI
Klaus E Veitinger, MD, PhDDirectorMilwaukee, WI
David E Baker, PhDDirectorMilwaukee, WI
Ed E Barthell, MDDirectorMequon, WI
Chad E Beyer, PhDDirectorMilwaukee, WI
Chad E Beyer, PhDExecutive OfficerMilwaukee, WI
Daniel E LawtonDirectorMilwaukee, WI
Patrick E Schwarz-SchuetteDirectorDusseldorf, 2M
Virinder E Nohria, PhDDirectorMilwaukee, WI
Ed A Barthell, MDDirectorMequon, WI
Virinder A Nohria, PhDDirectorMilwaukee, WI
Thomas A ShannonDirectorSaukville, WI
Klaus A Veitinger, MD, PhDDirectorMilwaukee, WI
Patrick A Schwarz-SchuetteDirector40213 Dusseldorf, 2M
Daniel A LawtonDirectorMilwaukee, WI

Other filings by this issuer (6)

FiledFormOfferingSold
2019-12-27D$6.0M$2.5M
2017-09-25D$17.6M$17.6M
2016-10-05D$8.8M$8.8M
2014-01-15D$2.9M$820K
2013-04-01D$750K$750K
2009-08-31D/A$2.5M$1.7M

More